Literature DB >> 1913619

Low incidence of Ha-ras oncogene mutations in human epidermal tumors.

F M Lieu1, K Yamanishi, K Konishi, S Kishimoto, H Yasuno.   

Abstract

Activation of the Ha-ras oncogene by point mutations has been suggested to play a role in animal skin carcinogenesis models. In this study, we investigated the significance of the Ha-ras mutations in human epidermal tumors. DNAs from paraffin-embedded tissues of benign and malignant human epidermal tumors (27 samples from 25 patients) were prepared and examined for point mutations of codons 12, 13 and 61 of Ha-ras gene by polymerase chain reaction and oligonucleotide hybridization. Only one sample of basal cell carcinoma and one sample of keratoacanthoma were found to carry an A to T transversion at the second position of codon 61. This low incidence of Ha-ras mutations suggests that the mutational activation of the gene may not be primarily involved in human epidermal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913619     DOI: 10.1016/0304-3835(91)90146-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.

Authors:  Courtney T Luke; Carolyn E Oki-Idouchi; J Mark Cline; Patricia S Lorenzo
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

2.  Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.

Authors:  Alexandra Montagner; Maria B Delgado; Corinne Tallichet-Blanc; Jeremy S K Chan; Ming K Sng; Hélén Mottaz; Gwendoline Degueurce; Yannick Lippi; Catherine Moret; Michael Baruchet; Maria Antsiferova; Sabine Werner; Daniel Hohl; Talal Al Saati; Pierre J Farmer; Nguan S Tan; Liliane Michalik; Walter Wahli
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

3.  Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.

Authors:  E Holmberg; B L Rozell; R Toftgård
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.